Chapter 1. Preface
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global Active pharmaceutical ingredient Market, 2015 - 2021, (USD Billion)
2.2. Active pharmaceutical ingredient: Market snapshot
Chapter 3. Active pharmaceutical ingredient Market: Industry Analysis
3.1. Active pharmaceutical ingredient: Market dynamics
3.2. Market Drivers
3.2.1. Increasing prevalence of chronic diseases
3.2.2. Technological advancements in the API
3.2.3. Patent expiration of major drugs that increased generic drug sales
3.2.4. Government initiatives
3.3. Restraints
3.3.1. Stringent regulatory requirement
3.3.2. Decline in global economics
3.4. Opportunity
3.4.1. Demand for active pharmaceutical ingredient for various diseases treatment
3.5. Porters Five Forces Analysis
3.6. Market Attractiveness Analysis
3.6.1. Market attractiveness analysis by API synthesis segment
3.6.2. Market attractiveness analysis by type of manufacturing segment
3.6.3. Market attractiveness analysis by type of API segment
3.6.4. Market attractiveness analysis by drug type segment
3.6.5. Market attractiveness analysis by Application segment
3.6.6. Market attractiveness analysis by region segment
Chapter 4. Global Active pharmaceutical ingredient Market: Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global active pharmaceutical ingredient market: company market share, 2015
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Product Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Product and Regional Expansion
4.3. Price Trend Analysis
4.4. Product Portfolio
4.5. Patent Analysis (2011-2016)
4.5.1. Patent Trend
4.5.2. Patent Share by company
4.5.3. By Region
Chapter 5. Global Active pharmaceutical ingredient Market: API Synthesis Type Overview
5.1. Global active pharmaceutical ingredient market share, by API Synthesis type, 2015 and 2021
5.2. Global active pharmaceutical ingredient market for biotech APItype, 2015 - 2021(USD Billion)
5.3. Global active pharmaceutical ingredient market for synthetic chemical API, 2015 - 2021 (USD Billion)
5.4. Global active pharmaceutical ingredient market for HPAPI type, 2015 - 2021 (USD Billion)
Chapter 6. Global active pharmaceutical ingredient Market: Type of Manufacturing Overview
6.1. Global active pharmaceutical ingredient market share, by type of Manufacturing, 2015 and 2021
6.2. Global active pharmaceutical ingredient market for contract manufacturing, 2015 - 2021(USD Billion)
6.3. Global active pharmaceutical ingredient market for in-house API manufacturing, 2015 - 2021 (USD Billion)
Chapter 7. Global active pharmaceutical ingredient Market: Type of API Overview
7.1. Global active pharmaceutical ingredient market share for type of API , 2015 and 2021
7.2. Global active pharmaceutical ingredient market for synthetic API, 2015 - 2021(USD Billion)
7.3. Global active pharmaceutical ingredient market for biological API, 2015 - 2021 (USD Billion)
Chapter 8. Global active pharmaceutical ingredient Market: Drug Type Overview
8.1. Global active pharmaceutical ingredient market share for type of drug, 2015 and 2021
8.2. Global active pharmaceutical ingredient market for branded drugs, 2015 - 2021(USD Billion)
8.3. Global active pharmaceutical ingredient market for generic drugs, 2015 - 2021 (USD Billion)
8.4. Global active pharmaceutical ingredient market for OTC drugs, 2015 - 2021 (USD Billion)
Chapter 9. Global active pharmaceutical ingredient Market: Application Overview
9.1. Global active pharmaceutical ingredient market share for application , 2015 and 2021
9.2. Global active pharmaceutical ingredient market for cardiology, 2015 - 2021(USD Billion)
9.3. Global active pharmaceutical ingredient market for oncology, 2015 - 2021 (USD Billion)
9.4. Global active pharmaceutical ingredient market for anti-inflammatory, 2015 - 2021 (USD Billion)
9.5. Global active pharmaceutical ingredient market for gastrointestinal, 2015 - 2021 (USD Billion)
9.6. Global active pharmaceutical ingredient market for others, 2015 - 2021 (USD Billion)
Chapter 10. Global active pharmaceutical ingredient Market: Regional Analysis
10.1. Global active pharmaceutical ingredient market: Regional overview
10.1.1. Global active pharmaceutical ingredient market share, by region, 2015 and 2021
10.2. North America
10.2.1. North America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.2.2. North America active pharmaceutical ingredient market revenue, type of Manufacturing, 2015 2021 (USD Billion)
10.2.3. North America active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion)
10.2.4. North America active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion)
10.2.5. North America active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion)
10.2.6. U.S.
10.2.6.1. U.S active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.2.6.2. U.S active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.2.6.3. U.S active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion)
10.2.6.4. U.S active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion)
10.2.6.5. U.S active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion)
10.3. Europe
10.3.1. Europe active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.3.2. Europe active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.3.3. Europe active pharmaceutical ingredient market revenue, by type of API , 2015 2021 (USD Billion)
10.3.4. Europe active pharmaceutical ingredient market revenue, by drug type , 2015 2021 (USD Billion)
10.3.5. Europe active pharmaceutical ingredient market revenue, by application , 2015 2021 (USD Billion)
10.3.6. UK
10.3.6.1. UK active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.3.6.2. UK active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.3.6.3. UK active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion)
10.3.6.4. UK active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion)
10.3.6.5. UK active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion)
10.3.7. France
10.3.7.1. France active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.3.7.2. France active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.3.7.3. France active pharmaceutical ingredient market revenue, by type of API 2015 2021 (USD Billion)
10.3.7.4. France active pharmaceutical ingredient market revenue, by drug type 2015 2021 (USD Billion)
10.3.7.5. France active pharmaceutical ingredient market revenue, by application 2015 2021 (USD Billion)
10.3.8. Germany
10.3.8.1. Germany active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.3.8.2. Germany active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.3.8.3. Germany active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion)
10.3.8.4. Germany active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion
10.3.8.5. Germany active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion
10.4. Asia Pacific
10.4.1. Asia Pacific active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.4.2. Asia Pacific active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.4.3. Asia Pacific active pharmaceutical ingredient market revenue, by type of API , 2015 5 2021 (USD Billion)
10.4.4. Asia Pacific active pharmaceutical ingredient market revenue, by drug type , 2015 5 2021 (USD Billion)
10.4.5. Asia Pacific active pharmaceutical ingredient market revenue, by application , 2015 5 2021 (USD Billion)
10.4.6. China
10.4.6.1. China active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.4.6.2. China active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.4.6.3. China active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion)
10.4.6.4. China active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion)
10.4.6.5. China active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion)
10.4.7. India
10.4.7.1. India active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.4.7.2. India active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.4.7.3. India active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion)
10.4.7.4. India active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion)
10.4.7.5. India active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion)
10.5. Latin America
10.5.1. Latin America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.5.2. Latin America active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.5.3. Latin America active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion)
10.5.4. Latin America active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion)
10.5.5. Latin America active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion)
10.5.6. Brazil
10.5.6.1. Brazil active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.5.6.2. Brazil active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.5.6.3. Brazil active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion)
10.5.6.4. Brazil active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion)
10.5.6.5. Brazil active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion)
10.6. Middle East Africa
10.6.1. Middle East Africa active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion)
10.6.2. Middle East Africa active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion)
10.6.3. Middle East Africa active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion)
10.6.4. Middle East Africa active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion)
10.6.5. Middle East Africa active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion)
Chapter 11. Company Profiles
11.1. Novartis International AG
11.1.1. Overview
11.1.2. Financials
11.1.3. Product portfolio
11.1.4. Business strategy
11.1.5. Recent developments
11.2. Pfizer
11.2.1. Overview
11.2.2. Financials
11.2.3. Product portfolio
11.2.4. Business strategy
11.2.5. Recent developments
11.3. Aurobindo
11.3.1. Overview
11.3.2. Financials
11.3.3. Product portfolio
11.3.4. Business strategy
11.3.5. Recent developments
11.4. Albemarle Corporation
11.4.1. Overview
11.4.2. Financials
11.4.3. Product portfolio
11.4.4. Business strategy
11.4.5. Recent developments
11.5. Boehringer Ingelheim
11.5.1. Overview
11.5.2. Financials
11.5.3. Product portfolio
11.5.4. Business strategy
11.5.5. Recent developments
11.6. BASF SE
11.6.1. Overview
11.6.2. Financials
11.6.3. Product portfolio
11.6.4. Business strategy
11.6.5. Recent developments
Chapter 12. Patents
12.1. U.S. (US Patents)
12.2. Europe (EP documents)
12.3. Japan (Abstracts of Japan)
12.4. Global (WIPO (PCT))
